Eisai starts phase 3 trials for second Alzheimer's drug after first's failure - Global News | Latest & Current News - Weather, Sports & Health News

Post Top Ad

Responsive Ads Here

Eisai starts phase 3 trials for second Alzheimer's drug after first's failure

Share This
Eisai Co Ltd on Friday said it has begun phase 3 clinical trials of Alzheimer's treatment BAN2401, a day after the Japanese drugmaker and U.S. partner Biogen Inc scrapped trials for another Alzheimer's drug, aducanumab.


from Reuters: Money News https://ift.tt/2TP1EJu

No comments:

Post a Comment

Post Bottom Ad

Responsive Ads Here

Pages